157 related articles for article (PubMed ID: 9082652)
1. [Pathogenesis of multiple sclerosis: status of research].
Hartung HP
Wien Med Wochenschr; 1996; 146(19-20):520-7. PubMed ID: 9082652
[TBL] [Abstract][Full Text] [Related]
2. Immunobiology of oligodendrocytes in multiple sclerosis.
Ruffini F; Chojnacki A; Weiss S; Antel JP
Adv Neurol; 2006; 98():47-63. PubMed ID: 16400826
[No Abstract] [Full Text] [Related]
3. Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factor-alpha-induced oligodendrocyte apoptosis.
Vanderlocht J; Hellings N; Hendriks JJ; Vandenabeele F; Moreels M; Buntinx M; Hoekstra D; Antel JP; Stinissen P
J Neurosci Res; 2006 Apr; 83(5):763-74. PubMed ID: 16477612
[TBL] [Abstract][Full Text] [Related]
4. Positive and negative implications of tumor necrosis factor neutralization for the pathogenesis of multiple sclerosis.
Taoufik E; Tseveleki V; Euagelidou M; Emmanouil M; Voulgari-Kokota A; Haralambous S; Probert L
Neurodegener Dis; 2008; 5(1):32-7. PubMed ID: 18075273
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
Dhib-Jalbut S
Neurology; 2007 May; 68(22 Suppl 3):S13-21; discussion S43-54. PubMed ID: 17548563
[TBL] [Abstract][Full Text] [Related]
6. The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis.
van Noort JM; van Sechel AC; Bajramovic JJ; el Ouagmiri M; Polman CH; Lassmann H; Ravid R
Nature; 1995 Jun; 375(6534):798-801. PubMed ID: 7596414
[TBL] [Abstract][Full Text] [Related]
7. Proinflammatory cytokines regulate antigen-independent T-cell activation by two separate calcium-signaling pathways in multiple sclerosis patients.
Martino G; Grohovaz F; Brambilla E; Codazzi F; Consiglio A; Clementi E; Filippi M; Comi G; Grimaldi LM
Ann Neurol; 1998 Mar; 43(3):340-9. PubMed ID: 9506551
[TBL] [Abstract][Full Text] [Related]
8. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes.
Tan L; Gordon KB; Mueller JP; Matis LA; Miller SD
J Immunol; 1998 May; 160(9):4271-9. PubMed ID: 9574529
[TBL] [Abstract][Full Text] [Related]
9. [Perspectives in multiple sclerosis research].
Lassmann H
Wien Med Wochenschr; 1996; 146(19-20):528-32. PubMed ID: 9082653
[TBL] [Abstract][Full Text] [Related]
10. Influence of neurosteroids on the pathogenesis of multiple sclerosis.
Leitner H
Med Hypotheses; 2010 Aug; 75(2):229-34. PubMed ID: 20227191
[TBL] [Abstract][Full Text] [Related]
11. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting.
Stinissen P; Raus J
Acta Neurol Belg; 1999 Mar; 99(1):65-9. PubMed ID: 10218096
[TBL] [Abstract][Full Text] [Related]
12. Immune-mediated demyelination.
Hartung HP
Ann Neurol; 1993 Jun; 33(6):563-7. PubMed ID: 8498835
[TBL] [Abstract][Full Text] [Related]
13. DNA-based vaccines: the future of multiple sclerosis therapy?
Stüve O; Cravens PD; Eagar TN
Expert Rev Neurother; 2008 Mar; 8(3):351-60. PubMed ID: 18345967
[TBL] [Abstract][Full Text] [Related]
14. [Activation of T cells in experimental autoimmune encephalomyelitis and multiple sclerosis].
Rodríguez-Rodríguez Y; Suárez-Luis I
Rev Neurol; 2003 Apr 1-15; 36(7):649-52. PubMed ID: 12666047
[TBL] [Abstract][Full Text] [Related]
15. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
[TBL] [Abstract][Full Text] [Related]
16. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis.
Mastronardi FG; Moscarello MA
J Neurosci Res; 2005 May; 80(3):301-8. PubMed ID: 15704220
[TBL] [Abstract][Full Text] [Related]
17. Do microbes with peptides mimicking myelin cause multiple sclerosis if the T cell response to their unique peptides is limited?
Kaufman MD
J Theor Biol; 1998 Aug; 193(4):691-708. PubMed ID: 9745761
[TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.
Storch MK; Piddlesden S; Haltia M; Iivanainen M; Morgan P; Lassmann H
Ann Neurol; 1998 Apr; 43(4):465-71. PubMed ID: 9546327
[TBL] [Abstract][Full Text] [Related]
19. Effect of interferon gamma on T lymphocytes from patients with multiple sclerosis.
Grimaldi LM; Martino G
Mult Scler; 1995; 1 Suppl 1():S38-43. PubMed ID: 9345397
[TBL] [Abstract][Full Text] [Related]
20. Restoring immune suppression in the multiple sclerosis brain.
Koning N; Uitdehaag BM; Huitinga I; Hoek RM
Prog Neurobiol; 2009 Dec; 89(4):359-68. PubMed ID: 19800386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
